@article {3301,
	title = {A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.},
	journal = {Journal of acquired immune deficiency syndromes (1999)},
	volume = {60},
	year = {2012},
	month = {2012 Jun 1},
	pages = {150-7},
	abstract = {The optimal approach to HIV-associated Kaposi sarcoma (HIV-KS) in sub-Saharan Africa is unknown. With large-scale rollout of highly active antiretroviral therapy (HAART) in South Africa, we hypothesized that survival in HIV-KS would improve and administration of chemotherapy in addition to HAART would be feasible and improve KS-specific outcomes.},
	keywords = {Adult, Anti-HIV Agents, Antigens, Neoplasm, Antiretroviral Therapy, Highly Active, Drug Therapy, Female, Humans, Lamivudine, Male, Nevirapine, Sarcoma, Kaposi, South Africa, Stavudine, Survival Analysis, Treatment Outcome},
	issn = {1944-7884},
	doi = {10.1097/QAI.0b013e318251aedd},
	author = {Mosam, Anisa and Shaik, Fahmida and Uldrick, Thomas S and Esterhuizen, Tonya and Friedland, Gerald H and Scadden, David T and Aboobaker, Jamila and Coovadia, Hoosen M}
}
